MedPath

Comparison of the efficacy of two therapeutic regimens for primary nocturnal enuresis; oxybutnin plus desmopressin versus desmopressin in pediatric patients

Not Applicable
Conditions
Primary nocturnal enuresis.
Nonorganic enuresis
Registration Number
IRCT201301117892N4
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

(5 to 18 year-old patients with primary nocturnal enuresis)
Exclusion criteria: (to have neurogenic bladder; CNS disorders; secondary nocturnal enuresis; occurrence of drug side effects)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of nocturnal urination in a week. Timepoint: weekly for 12 weeks. Method of measurement: Using a questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath